People with O positive blood can absolutely get HIV. No ABO blood type, including O positive, provides protection against the virus. HIV infects the body through a mechanism that has nothing to do with the A, B, or O antigens on red blood cells, and multiple large studies have found no meaningful link between any blood group and HIV risk. The idea that certain blood types might shield someone from HIV circulates online, but the epidemiological evidence consistently points in the same direction: the virus does not care what blood type you are.
How HIV Actually Enters the Body
The reason blood type is irrelevant to HIV infection comes down to how the virus gets inside cells. HIV targets a specific receptor called CD4, which sits on the surface of certain immune cells, particularly a type of white blood cell called a T-helper cell. After latching onto CD4, the virus needs a second handhold on the cell surface, a coreceptor called either CCR5 or CXCR4, depending on the viral strain. These coreceptors are what allow the virus to fuse with the cell membrane and inject its genetic material.1Europe PMC. The biology of CCR5 and CXCR4
Blood group antigens, the molecules that determine whether you are type A, B, AB, or O, sit on the surface of red blood cells and some other tissues. They are not involved in the CD4-CCR5/CXCR4 docking process that HIV depends on. This is the fundamental reason blood type does not influence whether the virus can infect you. It would be a bit like asking whether the color of your front door affects whether someone can pick the lock on your back door. The virus is using an entirely different set of molecular keys.
What the Epidemiological Evidence Shows
Researchers have tested the blood-type question directly, and the results are clear. A study of blood donors in Côte d’Ivoire found no statistical association between ABO blood groups and HIV infection, and the Rh system (positive or negative) had no effect either.2PubMed Central. ABO/Rh Blood Groups and Risk of HIV Infection and Hepatitis B Among Blood Donors of Abidjan, Côte D’ivoire – Section: Results A large South African study examining the question with adjusted statistical models reached the same conclusion: after accounting for age, sex, race, and province, HIV infection was not associated with any ABO blood group. That study did note a weak, borderline association with Rh-positive status, but the effect was small and only marginally significant.3PubMed Central. Association of ABO and RhD blood groups with the risk of HIV infection – Section: Results
A Nigerian study of over 2,300 blood donors found that blood group O had the highest number of HIV-positive individuals, with 13 cases. But group O also made up nearly 79% of the donor pool in that population, so the raw count simply reflected the fact that O is the most common blood type in West Africa, not that O-positive people are more vulnerable.4PubMed Central. Distribution of ABO and rhesus blood grouping with HIV infection among blood donors in Ekiti State Nigeria – Section: Results This is the kind of finding that can easily be misread if you glance at a headline without considering the denominator.
The broadest look at the question comes from a systematic review and meta-analysis that pooled data from 50 observational studies covering more than three million participants and over 6,500 HIV cases.5PubMed. ABO blood groups and risk of human immunodeficiency virus infection: A systematic review and meta-analysis That kind of sample size has real statistical power to detect even small effects. The takeaway across this body of research is consistent: ABO blood type does not meaningfully predict who gets HIV.
Where the Myth Comes From
Blood type does matter for some infectious diseases, and this is likely where the confusion starts. Etiological studies have connected blood type O with higher rates of cholera, plague, and tuberculosis, while type A has been linked with smallpox susceptibility and type B with gonorrhea and certain bacterial infections.6PubMed Central. Human ABO Blood Groups and Their Associations with Different Diseases More recently, a meta-analysis found that people with blood type O had modestly higher odds of norovirus infection compared to other types.7PubMed. ABO blood group-associated susceptibility to norovirus infection: A systematic review and meta-analysis – Section: RESULTS
These associations exist because some pathogens interact with the sugar molecules that define blood group antigens, or because the presence or absence of certain antigens affects how the immune system recognizes the pathogen. Norovirus, for instance, binds directly to blood group antigens on gut lining cells, which is why the A, B, or O profile on those cells actually matters. HIV does not use this pathway. It has its own dedicated receptor system, so the disease associations that are real for gut pathogens or certain bacteria simply do not transfer to a retrovirus that targets immune cells via CD4.
There is also a popular-culture ecosystem of blood type personality theories and blood type diets that encourages people to think of their ABO group as a deeper biological identity than it actually is. In reality, the ABO system is one of hundreds of blood group systems, and while it matters enormously for transfusion safety and has some genuine disease associations, it is not a master key to health or susceptibility.
The Secretor Status Wrinkle
There is one blood-group-adjacent factor that researchers have looked at with some interesting results, but it is not what most people mean when they ask about blood type. It involves something called secretor status. About 80% of people are “secretors,” meaning they express their blood group antigens not just on red blood cells but also on the surface of epithelial cells lining their mucous membranes and in bodily secretions like saliva and genital fluids. The remaining 20% are “non-secretors” who lack a functional copy of the FUT2 gene responsible for this expression.8University of Nairobi. Secretor status, fucosyltransferase 2 (fut2) gene polymorphisms and susceptibility to HIV infections among female sex workers in Nairobi, Kenya – Section: Abstract
A study among Senegalese sex workers found that non-secretors, those who do not express blood group antigens on mucosal surfaces, had substantially lower odds of HIV-1 infection. The adjusted odds ratio was 0.18, meaning non-secretors in that group had roughly one-fifth the risk of secretors. For HIV-2, the trend went in the same direction but was not statistically significant.9PubMed. Secretor polymorphism and human immunodeficiency virus infection in Senegalese women The researchers proposed that modifying the carbohydrate landscape on mucosal cell surfaces might affect heterosexual HIV transmission at the point of entry.
This is a genuinely interesting finding, but it is important to be precise about what it does and does not mean. Secretor status is not the same thing as blood type. You can be type O and a secretor, or type O and a non-secretor. The FUT2 gene controls whether your ABO antigens show up on mucosal surfaces, but it does not determine what those antigens are. So even if the secretor effect turns out to be robust across larger studies, it would not mean that a particular ABO type protects against HIV. It would mean that the presence or absence of blood group sugars on genital mucosal cells might influence the earliest steps of sexual transmission, which is a different question entirely.
Sugar Molecules on the Virus Itself
HIV’s outer envelope is heavily decorated with sugar molecules called glycans, and these sugars play a role in how the virus interacts with the immune system. The viral surface protein gp120, the protein that grabs onto CD4, is one of the most densely glycosylated proteins known. These sugars help shield the virus from antibodies and also interact with host cell lectins, sugar-binding proteins on immune cells that the virus essentially hijacks to spread through the body.10PubMed Central. Functional contributions of carbohydrate on AIDS virus glycoprotein – Section: Abstract
Research on the specific types of glycans decorating gp120 has identified at least four structural types, including high-mannose glycans and complex branched structures. Lectins that recognize these sugar structures can actually block the fusion of HIV-infected cells with uninfected CD4 cells in laboratory experiments.11PubMed. Correlation between carbohydrate structures on the envelope glycoprotein gp120 of HIV-1 and HIV-2 and syncytium inhibition with lectins More recent work has shown that certain bacterial lectins found in oral bacteria can bind to the sugar coat on HIV and actually enhance the virus’s ability to infect cells and resist neutralizing antibodies.12iScience. HIV-1 interaction with an O-glycan-specific bacterial lectin enhances virus infectivity and resistance to neutralizing antibodies – Section: Results
These glycan interactions are genuinely important to how HIV evades the immune system and spreads within the body. But they involve sugars on the virus and sugars on immune cells, not the ABO blood group sugars on red blood cells. The shared vocabulary of “glycans” and “carbohydrates” can make it seem like blood type sugars and viral envelope sugars are part of the same story. They are not. The glycan shield on HIV is a product of the virus’s own machinery hijacking the host cell’s sugar-adding equipment during viral replication. Your ABO type does not change what sugars the virus puts on its surface.
Blood Donation Screening and Type O
One practical context where blood type and HIV collide is blood donation. Because O positive is the most commonly needed blood type in transfusion medicine, O-positive donors are heavily recruited at blood banks worldwide. Every donated unit is screened for HIV regardless of the donor’s blood type. Modern screening uses layered testing methods. In one large cohort study of over 65,000 blood donors in eastern India, initial screening with an immunoassay flagged about 0.25% of donors as potentially HIV-positive, while the more sensitive nucleic acid testing confirmed a lower rate of about 0.08%. Nucleic acid testing also caught two window-period infections that the other methods missed entirely.13ScienceDirect / Elsevier (Transfusion and Apheresis Science). HIV screening in blood donation: Diagnostic accuracy of chemiluminescence and rapid test compared to nucleic acid test in a large-scale Eastern India cohort
The screening process is the same whether the donated blood is O positive, A negative, or any other type. There is no protocol that treats any blood group as lower-risk for HIV. This matters for donors to understand: being O positive confers no special status with respect to HIV screening, and it should not create a false sense of security about exposure risk.
Why the Rh-Positive Question Keeps Coming Up
The “O positive” framing of this question adds the Rh factor into the mix, and that is worth addressing separately. The Rh system refers primarily to the D antigen on red blood cells. If you have it, you are Rh-positive; if you lack it, you are Rh-negative. The South African study mentioned earlier found a weak, borderline statistical association between Rh-positive status and HIV infection, with the odds ratio sitting right at the edge of significance after adjustment for confounding factors.3PubMed Central. Association of ABO and RhD blood groups with the risk of HIV infection – Section: Results The Côte d’Ivoire study, by contrast, found no effect of the Rh system on HIV infection at all.2PubMed Central. ABO/Rh Blood Groups and Risk of HIV Infection and Hepatitis B Among Blood Donors of Abidjan, Côte D’ivoire – Section: Results
A borderline finding in one study that fails to replicate in another is exactly the kind of result that looks provocative in isolation but fades when you zoom out. Even if some tiny Rh-related effect existed, the magnitude reported would be far too small to have any practical meaning for an individual. It would not change anyone’s risk category, and it would not change any prevention recommendations. The practical answer remains the same: being Rh-positive does not meaningfully affect your HIV risk.
What Actually Determines HIV Risk
The factors that genuinely drive HIV transmission risk are well established, and none of them involve blood type. The major routes of transmission are unprotected sexual contact, sharing needles, and vertical transmission from mother to child during pregnancy, birth, or breastfeeding. Within those routes, the biggest determinants of risk include viral load in the infected person (people on effective antiretroviral therapy who have an undetectable viral load do not transmit the virus sexually), presence of other sexually transmitted infections that cause inflammation or open sores, circumcision status in men, and whether pre-exposure prophylaxis is being used.
The one genuine genetic factor that dramatically affects susceptibility is a mutation in the CCR5 gene called CCR5-delta32. People who carry two copies of this mutation lack functional CCR5 coreceptors on their cells, making them highly resistant to the most common strains of HIV. This mutation is found primarily in people of Northern European descent and is rare or absent in most other populations. It has nothing to do with blood type. Outside of that rare genetic variant, no heritable trait has been shown to provide meaningful protection against HIV.
Blood Type O and Diseases Where It Does Matter
If you have blood type O and are curious about where your blood type actually does influence health outcomes, the picture is more nuanced than the binary yes/no of HIV susceptibility. As noted earlier, type O has been linked to higher susceptibility to cholera and norovirus. On the other hand, type O consistently appears to be associated with lower risk of certain cardiovascular conditions. People with non-O blood types (A, B, and AB) tend to have higher levels of von Willebrand factor, a clotting protein, which may explain the modestly elevated rates of deep vein thrombosis and heart attack seen in those groups. Type O is also associated with lower risk of some cancers, including pancreatic and gastric cancer, in epidemiological studies.
These are population-level patterns that shift your odds at the margins, not destiny. The same applies to the handful of infectious diseases where blood type matters: the effect sizes are generally modest, and individual behavior, environment, and access to healthcare overwhelm any blood-type effect. For HIV specifically, the evidence is about as definitive as population-level research gets. Across millions of participants in dozens of studies, no ABO blood type, including O positive, has been found to protect against or meaningfully increase the risk of HIV infection. Prevention strategies, not blood type, determine your risk.